Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial

References

• BrookIGoberAERecovery of potential pathogens and interfering bacteria in the nasopharynx of otitis media-prone children and their smoking and nonsmoking parentsArch Otolaryngol Head Neck Surg200513150951215967884
   PubMedGoogle Scholar
• Sá-LeãoRNunesSBrito-AvôAHigh rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal studyJ Clin Microbiol20084622523418003797
   PubMed Web of Science ®Google Scholar
• HammittLLBrudenDLButlerJCIndirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: An explanation of trends in invasive pneumococcal diseaseJ Infect Dis20061931487149416652275
   PubMed Web of Science ®Google Scholar
• MurthyTFHaemophilus influenzaeMandellGLBennettJEDolinRPrinciples and Practice of Infectious Diseases6th edPhiladelphia, PAElsevier Churchill Livingstone2005
   Google Scholar
• Smith-VaughanHCLeachAJShelby-JamesTMKempKKempDJMathewsJDCarriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in aboriginal infants with otitis mediaEpidemiol Infect19961161771838620909
   PubMed Web of Science ®Google Scholar
• MusherDMStreptococcus pneumoniaeMandellGLBennettJEDolinRPrinciples and Practice of Infectious Diseases6th edPhiladelphia, PAElsevier Churchill Livingstone2005
   Google Scholar
• Sá-LeãoRTomaszASantos SanchesIde LencastreHPilot study of the genetic diversity of the pneumococcal nasopharyngeal flora among children attending day care centersJ Clin Microbiol2002403577358512354849
   PubMed Web of Science ®Google Scholar
• MelegaroAChoiYPebodyRGayNPneumococcal carriage in United Kingdom families: Estimating serotype-specific transmission parameters from longitudinal dataAm J Epidemiol200716622823517517684
   PubMed Web of Science ®Google Scholar
• EkdahlKAhlinderIHanssonHBDuration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention ProjectClin Infect Dis199725111311179402367
   PubMed Web of Science ®Google Scholar
• BisnoALStevensDLStreptococcus pyogenesMandellGLBennettJEDolinRPrinciples and Practice of Infectious Diseases6th edPhiladelphia, PAElsevier Churchill Livingstone2005
   Google Scholar
• CafiniFAguilarLSevillanoDDecrease in bacterial load versus resistance selection of pneumococcal subpopulations by β-lactam physiological concentrations over time: An in vitro pharmacodynamic simulationMicrobial Drug Res2008141321
   PubMed Web of Science ®Google Scholar
• SevillanoDAguilarLAlouLEffects of antimicrobials on the competitive growth of Streptococcus pneumoniae: A pharmacodynamic in vitro model approach to selection of resistant populationsJ Antimicrob Chemother20065879480116880173
   PubMed Web of Science ®Google Scholar
• BaqueroFModularization and evolvability in antibiotic resistanceBaqueroFNombelaCCassellGHGutierrez-FuentesJAEvolutionary Biology of Bacterial and Fungal PathogensWashington, DCASM Press2008
   Google Scholar
• CourvalinPAntimicrobial drug resistance: Prediction is very difficult, especially about the futureEmerg Infect Dis20051115031506
   Web of Science ®Google Scholar
• SmithDLLaxminarayanRHuman interventions on the evolution of host-bacterium interactionsBaqueroFNombelaCCassellGHGutierrez-FuentesJAEvolutionary Biology of Bacterial and Fungal PathogensWashington, DCASM Press2008
   Google Scholar
• KnudsenJDOdenholtIErlendsdottirHSelection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal modelsAntimicrob Agents Chemother2003472499250612878511
   PubMed Web of Science ®Google Scholar
• CamposJAracilBGarcia-CobosSOteoJEvolution of Haemophilus influenzae and Haemophilus infectionsBaqueroFNombelaCCassellGHGutierrez-FuentesJAEvolutionary Biology of Bacterial and Fungal PathogensWashington, DCASM Press2008
   Google Scholar
• TakahataSKatoYSanbongiYMaebashiKIdaTComparison of the efficacy of oral (beta)-lactams in selection of Haemophilus influenzae transformants with mutated fts I genesAntimicrob Agents Chemother2008521880188318347113
   PubMed Web of Science ®Google Scholar
• JönssonMSwedbergGMacrolide resistance can be transferred by conjugation from viridans streptococci to Streptococcus pyogenesInt J Antimicrob Agents20062810110316844354
   PubMed Web of Science ®Google Scholar
• AlouLGimenezMJSevillanoDA pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumoniaJ Antimicrob Chemother20065834935816782744
   PubMed Web of Science ®Google Scholar
• Garcia-ReyCFenollAAguilarLCasalJEffect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in SpainJ Antimicrob Chemother20045446547115269198
   PubMed Web of Science ®Google Scholar
• LlorCConsiderations for antibiotic prescription in primary careMed Clin Monogr (Barc)2004535257
   Google Scholar
• MogyorosMChallenges of managed care organisations in treating respiratory tract infections in an age of antibiotic resistanceAm J Manag Care20017Suppl 6163169
   Web of Science ®Google Scholar
• HuovinenPCarsOControl of antimicrobial resistance: Time for action. The essentials of control are already well knownBMJ19983176136149727984
   PubMed Web of Science ®Google Scholar
• GranizoJJAguilarLCasalJGarcía-ReyCDal-RéRBaqueroFStreptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979–1997)J Antimicrob Chemother20004676777311062196
   PubMed Web of Science ®Google Scholar
• García-ReyCAguilarLBaqueroFCasalJDal-RéRImportance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniaeJ Clin Microbiol20024015916411773111
   PubMed Web of Science ®Google Scholar
• GómezJRuiz-GómezJHernández-CardonaJLNuñezMLCanterasMValdésMAntibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: A prospective study in Murcia, Spain, 1983–1992Chemotherapy1994402993037956452
   PubMed Web of Science ®Google Scholar
• NissinenAGronroosPHuovinenPDevelopment of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978–1993Clin Infect Dis199521119311968589142
   PubMed Web of Science ®Google Scholar
• GranizoJJAguilarLCasalJDal-RéRBaqueroFStreptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986–1997)J Antimicrob Chemother20004695996411102415
   PubMed Web of Science ®Google Scholar
• García-ReyCAguilarLBaqueroFCasalJMartínJEPharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in SpainJ Clin Microbiol2002402959296312149359
   PubMed Web of Science ®Google Scholar
• Pérez-TralleroEGarcía-de-la-FuenteCGarcía-ReyCGeographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in SpainAntimicrob Agents Chemother2005491965197215855520
   PubMed Web of Science ®Google Scholar
• Gómez-LusRGranizoJJAguilarLBouzaEGutierrezAGarcía-de-LomasJIs there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory PathogensJ Clin Microbiol1999373384338610488213
   PubMed Web of Science ®Google Scholar
• FenollAGranizoJJAguilarLTemporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007J Clin Microbiol2009471012102019225097
   PubMed Web of Science ®Google Scholar
• FenollAAguilarLGranizoJJHas the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?J Antimicrob Chemother2008621430143318819966
   PubMed Web of Science ®Google Scholar
• WhitneyCGFarleyMMHadlerJDecline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccineN Engl J Med20033481737174612724479
   PubMed Web of Science ®Google Scholar
• Pérez-TralleroEFernández-MazarrasaCGarcía-ReyCAntimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998–1999) multicenter surveillance study in SpainAntimicrob Agents Chemother2001453334334011709305
   PubMed Web of Science ®Google Scholar
• CantónRUnalSFarrellDJAntibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1–5 (1999–2004)Int J Antimicrob Agents20073054655017931834
   PubMed Web of Science ®Google Scholar
• Pérez-TralleroEMarimónJMGonzálezAGarcía-ReyCAguilarLGenetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillinAntimicrob Agents Chemother2003473637363914576135
   PubMed Web of Science ®Google Scholar
• Pérez-TralleroEMarimónJMErcibengoaMGiménezMJCoronelPAguilarLAntimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniaeClin Microbiol Infect20071393794017617182
   PubMed Web of Science ®Google Scholar
• BaqueroFGarcía-RodríguezJAGarcía de LomasJAguilarLAntimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996–1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory PathogensAntimicrob Agents Chemother1999433573599925532
   PubMed Web of Science ®Google Scholar
• JenkinsSGFarrellDJIncrease in pneumococcus macrolide resistance, United StatesEmerg Infect Dis2009151260126419751588
   PubMed Web of Science ®Google Scholar
• PrietoJCalvoAGómez-LusMLAntimicrobial resistance: A class effect?J Antimicrob Chemother. 200250Suppl S2712
   Web of Science ®Google Scholar
• AlbertíSCortésGGarcía-ReyCStreptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: Mechanisms of resistance and clonal diversityAntimicrob Agents Chemother20054941842015616324
   PubMed Web of Science ®Google Scholar
• AlonsoRMateoEGalimandMGaraizarJCourvalinPCisternaRClonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenesJ Clin Microbiol2005432492249315872292
   PubMed Web of Science ®Google Scholar
• CarapetisJRSteerACMulhollandEKWeberMThe global burden of group A streptococcal diseasesLancet Infect Dis2005568569416253886
   PubMed Web of Science ®Google Scholar
• Malhotra-KumarSVan HeirstraetenLLammensCChapelleSGoossensHEmergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacinJ Antimicrob Chemother20096388689419279051
   PubMed Web of Science ®Google Scholar
• MontesMTamayoEOrdenBLarruskainJPerez-TralleroEPrevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in SpainAntimicrob Agents Chemother201054939719805559
   PubMed Web of Science ®Google Scholar
• García-RodríguezJABaqueroFGarcía de LomasJAguilarLAntimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain. Results of a 1-year (1996–97) multicenter surveillance study. Spanish Surveillance Group for Respiratory PathogensInfection19992726526710885840
   PubMed Web of Science ®Google Scholar
• MarcoFGarcía-de-LomasJGarcía-ReyCAntimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998–1999Antimicrob Agents Chemother2001453226322811600386
   PubMed Web of Science ®Google Scholar
• MaticVBozdoganBJacobsMRUbukataKAppelbaumPCContribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzaeJ Antimicrob Chemother2003521018102114585854
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards InstitutePerformance standards for antimicrobial susceptibility testing; nineteenth informational supplement. CLSI document M100-S19Wayne, PAClinical and Laboratory Standards Institute2009
   Google Scholar
• JansenWTVerelABeitsmaMVerhoefJMilatovicDLongitudinal European surveillance study of antibiotic resistance of Haemophilus influenzaeJ Antimicrob Chemother20065887387716891323
   PubMed Web of Science ®Google Scholar
• García-CobosSCamposJLázaroEAmpicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and cefiximeAntimicrob Agents Chemother2007512564257317470649
   PubMed Web of Science ®Google Scholar
• MacGowanAPElements of design: The knowledge on which we buildClin Microbiol Infect200410Suppl 261114759228
   PubMed Web of Science ®Google Scholar
• DrusanoGLAntimicrobial pharmacodynamics: Critical interactions of ‘bug and drug’Nat Rev Microbiol2004228930015031728
   PubMed Web of Science ®Google Scholar
• TurnidgeJPatersonDLSetting and revising antibacterial susceptibility breakpointsClin Microbiol Rev20072039140817630331
   PubMed Web of Science ®Google Scholar
• WellingtonKCurranMPCefditoren pivoxil: A review of its use in the treatment of bacterial infectionsDrugs2004642597261815516158
   PubMed Web of Science ®Google Scholar
• FenollAGiménezMJRobledoOInfluence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniaeEur J Clin Microbiol Infect Dis200827758017943330
   PubMed Web of Science ®Google Scholar
• FenollAGiménezMJRobledoOActivity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolonesInt J Antimicrob Agents20072922422617175141
   PubMed Web of Science ®Google Scholar
• Pérez-TralleroEMarimónJMErcibengoaMGiménezMJCoronelPAguilarLAntimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniaeClin Microbiol Infect20071393794017617182
   PubMed Web of Science ®Google Scholar
• García-de-LomasJLermaMCebriánLInfluence of Haemophilus influenzae beta-lactamase production and/or fts I gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporinsInt J Antimicrob Agents20073019019217459665
   PubMed Web of Science ®Google Scholar
• SevillanoDGiménezMJCercenadoEGenotypic versus phenotypic characterization, with respect to beta-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to beta-lactam resistance markersAntimicrob Agents Chemother20095326727018955529
   PubMed Web of Science ®Google Scholar
• GraciaMDíazCCoronelPAntimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005–06: Results of the Cefditoren Surveillance StudyJ Antimicrob Chemother2008611180118118316820
   PubMed Web of Science ®Google Scholar
• SádabaBAzanzaJRQuetglasEGPharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: A phase I studyRev Esp Quimioter200720516017530036
   PubMed Web of Science ®Google Scholar
• MoelleringRCEliopoulosGMPrinciples of anti-infective therapyMandellGLBennettJEDolinRPrinciples and Practice of Infectious Diseases6th edPhiladelphia, PAElsevier Churchill Livingstone2005
   Google Scholar
• SevillanoDAguilarLAlouLHigh protein binding and cidal activity against penicillin-resistant S. pneumoniae: A cefditoren in vitro pharmacodynamic simulationPLoS One200837e271718648650
   PubMed Web of Science ®Google Scholar
• GranizoJJSádabaBHonoratoJMonte Carlo simulation describing the pharmacodynamic profile of cefditoren in plasma from healthy volunteersInt J Antimicrob Agents20083139639818178067
   PubMed Web of Science ®Google Scholar
• CraigWAPharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and menClin Infect Dis1998261109455502
   PubMed Web of Science ®Google Scholar
• HeffelfingerJDDowellSFJorgensenJHManagement of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working GroupArch Intern Med20001601399140810826451
   PubMed Web of Science ®Google Scholar
• LodiseTPKinzig-SchippersMDrusanoGLUse of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluidAntimicrob Agents Chemother2008521945195117485507
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration www.fda.gov
   Google Scholar
• KarlowskyJAJonesMEDraghiDCCritchleyIAThornsberryCSahmDFIn vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditorenDiagn Microbiol Infect Dis200242596411821173
   PubMed Web of Science ®Google Scholar
• JohnsonDMBiedenbachDJBeachMLPfallerMAJonesRNAntimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus speciesDiagn Microbiol Infect Dis2000379910510863104
   PubMed Web of Science ®Google Scholar
• JonesRNBiedenbachDJCrocoMABarrettMSIn vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniaeDiagn Microbiol Infect Dis1998315735789764398
   PubMed Web of Science ®Google Scholar
• Agencia Española de Medicamentos y Productos Sanitarios Available at: https://sinaem4.agemed.es/consaem/fichasTecnicas.do?metodo=detalleForm. Accessed on Apr 29, 2010.
   Google Scholar
• GiménezMJGómez-LusMLValdésLAguilarLThe role of third-generation oral cephalosporin cefditoren pivoxil in the treatment of community-acquired infection in adultsRev Esp Quimioter20051821021616369662
   PubMedGoogle Scholar
• GranizoJJGiménezMJBarberánJCoronelPGimenoMAguilarLEfficacy of cefditoren in the treatment of upper respiratory tract infections: A pooled analysis of six clinical trialsRev Esp Quimioter200821142118443928
   PubMed Web of Science ®Google Scholar
• KaplanELTuckerRMPolingTLMarshDChowCManaging group A streptococcal infection. A multicenter comparison of cefditoren pivoxil and penicillin VKJ Resp Dis2001228 SupplS60S64
   Google Scholar
• GoochWMarshDSlicklerTHuntBCefditoren is safe and effective treatment for streptococcal pharyngitisAbstracts of the Fortieth Interscience Conference on Antimicrobial Agents and ChemotherapyToronto2000 Abstract 837 American Society for Microbiology. Washington, USA
   Google Scholar
• ChowJRussellMVolkSChowCEfficacy of cefditoren pivoxil (CDTR) versus amoxicillin/clavulanate (AMX/CLV) in acute maxillary sinusitis (AMS)Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and ChemotherapyToronto2000 Abstract 835. American Society for Microbiology. Washington, USA
   Google Scholar
• GranizoJJGiménezMJBarberánJCoronelPGimenoMAguilarLThe efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: A pooled analysis of seven clinical trialsClin Ther2006282061206917296462
   PubMed Web of Science ®Google Scholar
• van ZylLle RouxJGLaFataJACefditoren pivoxil versus cefpodoxime proxetil for community acquired pneumonia: Results of a multicenter, prospective, randomized, double-blind studyClin Ther2002241840185312501878
   PubMed Web of Science ®Google Scholar
• FogartyCMCyganowskiMPaloWAHomRCCraigWAA comparison of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of community-acquired pneumonia: A multicenter, prospective, randomized, investigator-blinded, parallel group studyClin Ther2002241854187012501879
   PubMed Web of Science ®Google Scholar
• Alvarez-SalaJLKardosPMartínez-BeltránJCoronelPAguilarLClinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetilAntimicrob Agents Chemother2006501762176716641447
   PubMed Web of Science ®Google Scholar
• RamirezJATuckerRMBettisRBTreating acute exacerbations of chronic bronchitisJ Resp Dis200122Suppl 8S75S80
   Google Scholar
• HenryDCPolingTLBettisRBA double-blind, randomized study of cefditoren vs cefuroxime for AECBJ Resp Dis200122Suppl 8S69S74
   Google Scholar
• GranizoJJAguilarLGimenezMJCoronelPGimenoMPrietoJSafety profile of cefditoren: A pooled analysis of data from clinical trials in community-acquired respiratory tract infectionsRev Esp Quimioter200922576119544097
   PubMed Web of Science ®Google Scholar
• AguilarLGiménezMJGaps in antibiotic development; the postmarketing gapsRev Med Microbiol20081917
   Web of Science ®Google Scholar
• SevillanoDAguilarLAlouLBeta-lactam effects on mixed cultures of common respiratory isolates as an approach to treatment effects on nasopharyngeal bacterial population dynamicsPLoS One20083e384619052648
   PubMed Web of Science ®Google Scholar